Incyte Corp - Net Worth and Insider Trading

Incyte Corp Net Worth

The estimated net worth of Incyte Corp is at least $7 Million dollars as of 2024-04-26. Incyte Corp is the 10% Owner of Agenus Inc and owns about 848,648 shares of Agenus Inc (AGEN) stock worth over $7 Million. Details can be seen in Incyte Corp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Incyte Corp has not made any transactions after 2020-06-17 and currently still holds the listed stock(s).

Transaction Summary of Incyte Corp

To

Incyte Corp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Incyte Corp owns 2 companies in total, including Agenus Inc (AGEN) , and Merus NV (MRUS) .

Click here to see the complete history of Incyte Corp’s form 4 insider trades.

Insider Ownership Summary of Incyte Corp

Ticker Comapny Transaction Date Type of Owner
AGEN Agenus Inc 2020-06-17 10 percent owner
MRUS Merus NV 2017-01-23 10 percent owner

Incyte Corp Latest Holdings Summary

Incyte Corp currently owns a total of 1 stock. Incyte Corp owns 848,648 shares of Agenus Inc (AGEN) as of June 17, 2020, with a value of $7 Million.

Latest Holdings of Incyte Corp

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AGEN Agenus Inc 2020-06-17 848,648 8.30 7,043,778

Holding Weightings of Incyte Corp


Incyte Corp Form 4 Trading Tracker

According to the SEC Form 4 filings, Incyte Corp has made a total of 2 transactions in Agenus Inc (AGEN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Agenus Inc is the sale of 10,700 shares on June 17, 2020, which brought Incyte Corp around $783,240.

Insider Trading History of Incyte Corp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Incyte Corp Trading Performance

GuruFocus tracks the stock performance after each of Incyte Corp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Incyte Corp is -16.14%. GuruFocus also compares Incyte Corp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Incyte Corp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Incyte Corp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Incyte Corp

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.55 -16.14 -14.32 -12.73 -10.3 -5.95
Relative Return to S&P 500(%) -10.74 -18.42 -19.81 -28.18 -18.68 -19.03

Incyte Corp Ownership Network

Ownership Network List of Incyte Corp

No Data

Ownership Network Relation of Incyte Corp


Incyte Corp Owned Company Details

What does Agenus Inc do?

Who are the key executives at Agenus Inc?

Incyte Corp is the 10 percent owner of Agenus Inc. Other key executives at Agenus Inc include Chairman & CEO Garo H Armen , Chief Medical Officer Steven J O'day , and VP Finance Christine M Klaskin .

Agenus Inc (AGEN) Insider Trades Summary

Over the past 18 months, Incyte Corp made no insider transaction in Agenus Inc (AGEN). Other recent insider transactions involving Agenus Inc (AGEN) include a net purchase of 500,000 shares made by Garo H Armen , and a net purchase of 25,000 shares made by Ulf Wiinberg .

In summary, during the past 3 months, insiders sold 0 shares of Agenus Inc (AGEN) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 0 shares of Agenus Inc (AGEN) were sold and 26,250 shares were bought by its insiders, resulting in a net purchase of 26,250 shares.

Agenus Inc (AGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Agenus Inc Insider Transactions

No Available Data

Incyte Corp Mailing Address

Above is the net worth, insider trading, and ownership report for Incyte Corp. You might contact Incyte Corp via mailing address: 1801 Augustine Cut-off, Wilmington De 19803.

Discussions on Incyte Corp

No discussions yet.